Full Text View
Tabular View
No Study Results Posted
Related Studies
Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)
This study has been completed.
Study NCT00077818   Information provided by Sanofi-Aventis
First Received: February 12, 2004   Last Updated: October 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Coronary Syndrome
Additional conditions recognized in this trial
Emergencies
Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Disease
Disease Attributes
Heart Diseases
Myocardial Ischemia
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Enoxaparin sodium
Additional drug interventions recognized in this trial
Enoxaparin
Heparin, Low-Molecular-Weight
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services